{"id":"NCT01676116","sponsor":"Novo Nordisk A/S","briefTitle":"The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy","officialTitle":"The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUALâ„¢ III -GLP-1 Switch)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08-29","primaryCompletion":"2014-03-11","completion":"2014-03-11","firstPosted":"2012-08-30","resultsPosted":"2018-07-09","lastUpdate":"2019-01-03"},"enrollment":438,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]},{"type":"DRUG","name":"liraglutide","otherNames":[]},{"type":"DRUG","name":"exenatide","otherNames":[]}],"arms":[{"label":"Insulin degludec/liraglutide + OADs","type":"EXPERIMENTAL"},{"label":"Liraglutide or exenatide + OADs","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Europe, Oceania and the United States of America (USA).\n\nThe aim of the trial is to investigate the efficacy of insulin degludec/liraglutide in controlling glycaemia in adults with type 2 diabetes inadequately controlled on glucagon-like peptide-1 (GLP-1) receptor agonist and OAD therapy.","primaryOutcome":{"measure":"Change in Glycosylated Haemoglobin (HbA1c) From Baseline (Randomisation, Visit 2)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"Insulin Degludec/Liraglutide + Oral Anti Diabetic Drugs (OADs)","deltaMin":-1.32,"sd":0.05},{"arm":"Liraglutide or Exenatide + OADs","deltaMin":-0.37,"sd":0.07}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":109,"countries":["United States","Australia","France","Hungary","Slovakia"]},"refs":{"pmids":["27943107","30383495","39963952"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":291},"commonTop":["Nasopharyngitis","Headache","Lipase increased","Upper respiratory tract infection","Diarrhoea"]}}